Jacobs Levy Equity Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Buy |
+950,507
| New | +$5.05M | 0.02% | 431 |
|
|
2021
Q1 | – | Sell |
-62,922
| Closed | -$1.24M | – | 1085 |
|
|
2020
Q4 | $1.24M | Sell |
62,922
-711,567
| -92% | -$14.1M | 0.01% | 668 |
|
|
2020
Q3 | $10.1M | Buy |
774,489
+645,116
| +499% | +$8.41M | 0.1% | 210 |
|
|
2020
Q2 | $1.47M | Buy |
+129,373
| New | +$1.47M | 0.02% | 587 |
|
|
2017
Q3 | – | Sell |
-65,900
| Closed | -$1.7M | – | 1001 |
|
|
2017
Q2 | $1.7M | Sell |
65,900
-219,930
| -77% | -$5.68M | 0.04% | 465 |
|
|
2017
Q1 | $5.49M | Buy |
285,830
+64,200
| +29% | +$1.23M | 0.11% | 234 |
|
|
2016
Q4 | $3.7M | Sell |
221,630
-231,996
| -51% | -$3.87M | 0.07% | 299 |
|
|
2016
Q3 | $9.34M | Buy |
+453,626
| New | +$9.34M | 0.17% | 174 |
|